Stock overview
Aligos Therapeutics, Inc.
Explore the company, reported ownership, price history, and available source evidence.
Aligos Therapeutics, Inc. (ALGS) is a healthcare or biotechnology equity security tracked from 13F filings.
- Last close
- $5.51
- · ALGS
- Tracked holders
- 2 funds
- Latest available 13F per fund
ALGS · USD
Price
$5.51
-$389.74
(-98.61%)
over selected range
Close · Sep 25, 2026
Market closed
1255 stored daily closes
$5.51
Sep 25, 2026
- Range low
- $3.99
- Range high
- $442.25
- Observations
- 1255
- Session date
- Sep 25, 2026
Sep 27, 2021–Sep 25, 2026. Regular market hours only. Historical prices are unadjusted; splits and other corporate actions can affect comparisons.
Investor Popularity
Rows are narrowed by movement, fund type, and position size.
| Fund | Move | Value | Weight |
|---|---|---|---|
| Renaissance Technologies position history Q2 2026 · filed Aug 13, 2026 · SEC filing | −89% 26'Q2 | $62,316 | 0% |
SEC Forms 4/5
Insiders
Financials
Official-source analysis
AI Earnings Report
No published AI Earnings Report yet
We publish a cited AI Earnings Report after an eligible official earnings filing is accepted and passes validation.
Options market